Avoid common mistakes on your manuscript.
Correction to: International Journal of Clinical Pharmacy https://doi.org/10.1007/s11096-023-01673-y
In the original publication of the article, the corresponding author Prof. Wei Zhuang’s e-mail address is corrected from zhuangw8@mail.sysu.edu.cn to zhuangwei1333@gmail.com.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Lin, W., Xu, J., Liao, Y. et al. Author Correction: Assessing safety concerns of interstitial lung disease associated with antibody-drug conjugates: a real-world pharmacovigilance evaluation of the FDA adverse event reporting system. Int J Clin Pharm 46, 776 (2024). https://doi.org/10.1007/s11096-024-01728-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-024-01728-8